Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejphar.2024.177161
PubMed Identifier: 39615869
Publication URI: http://europepmc.org/abstract/MED/39615869
Type: Journal Article/Review
Volume: 987
Parent Publication: European journal of pharmacology
ISSN: 0014-2999